ID
35684
Descripción
Study ID: 101468/192 Clinical Study ID: 101468/192 Study Title:A 52 Week Open-Label Extension Study of the Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The study consists of 16 visits which are devided in 3 study books: Book 1: Screening (+Baseline), Day 2, Week 1, Week 2 , Week 3 , Week 4, Week 5, Week 6, Week 7, Week 8 Book 2: Week 12, Week 24, Week 36, Week 48, Week 52, Follow-up Book 3: Early withdrawal and Follow-up Each follow-up Visit takes place 7 +/- 3 days after last dose This document contains the Study Medication And Compliance Record form. It has to be filled in for each Visit. It also cntains the Dose reduction due to AE form. It has to be filled in for Week 12-48 and Follow-up.
Palabras clave
Versiones (1)
- 15/3/19 15/3/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
15 de marzo de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS), 101468/192
Study Medication And Compliance Record, Dose reduction due to AE
- StudyEvent: ODM
Descripción
Study Medication And Compliance Record
Alias
- UMLS CUI-1
- C2734539
- UMLS CUI-2
- C0008972
- UMLS CUI-3
- C1321605
Descripción
Week Number
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0439230
- UMLS CUI [1,2]
- C0237753
Descripción
Dose Level
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0178602
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1]
- C3173309
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C0011008
Descripción
Number of tablets dispensed
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0304229
Descripción
Number of tablets returned
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0304229
Descripción
Dose Reductions Due to Adverse Experiences
Alias
- UMLS CUI-1
- C1707814
- UMLS CUI-2
- C0559546
Descripción
Week
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0439230
Descripción
Dose Level
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0178602
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1]
- C3173309
Descripción
day month year
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C0011008
Descripción
Number of tablets dispensed
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0304229
Descripción
Number of tablets returned
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0304229
Similar models
Study Medication And Compliance Record, Dose reduction due to AE
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C0008972 (UMLS CUI-2)
C1321605 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0559546 (UMLS CUI-2)
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Sin comentarios